Richard A Kayne insider trades: Eiger BioPharmaceuticals (EIGR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
and 6 more companies
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2023 | EIGR | ↑ Buy | 278,239 | $0.26 | $73K | Indirect | Nov 2, 2023 (0d) |
| May 1, 2019 | KRP | ↓ Sell | 3,200,000 | $16.25 | $52.0M | Direct | May 3, 2019 (2d) |
| Mar 27, 2019 | ALTM | ↓ Sell | 221,600 | $6.03 | $1.3M | Indirect | Mar 27, 2019 (0d) |
| Mar 13, 2019 | ALTM | ↓ Sell | 223,600 | $6.13 | $1.4M | Indirect | Mar 13, 2019 (0d) |
| Nov 9, 2018 | KAAC | ↑ Buy | 14,318,000 | $10.00 | $143.2M | See Remarks | Nov 14, 2018 (5d) |
| Nov 9, 2018 | KAAC | ↑ Buy | 200,000 | $10.00 | $2.0M | Direct | Nov 14, 2018 (5d) |
| Oct 2, 2018 | KMF | ↓ Sell | 20,000 | $13.00 | $260K | Indirect | Oct 4, 2018 (2d) |
| Jul 30, 2018 | KED | ↑ Buy | 2,000 | $17.53 | $35K | Indirect | Aug 1, 2018 (2d) |
| May 1, 2018 | KYN | ↑ Buy | 14,265 | $17.53 | $250K | Indirect | May 8, 2018 (7d) |
| May 24, 2017 | RSPP | ↓ Sell | 17,250,000 | $38.78 | $669.0M | Indirect | May 26, 2017 (2d) |
| Oct 26, 2016 | KYN | ↑ Buy | 25,500 | $19.45 | $496K | * | Oct 26, 2016 (0d) |
| Jan 20, 2016 | KYN | ↑ Buy | 25,450 | $10.58 | $269K | Direct | Jan 22, 2016 (2d) |
| Dec 4, 2015 | KYN | ↑ Buy | 18,500 | $16.50 | $305K | Direct | Dec 4, 2015 (0d) |
| Dec 3, 2015 | KYN | ↑ Buy | 15,250 | $17.16 | $262K | Direct | Dec 3, 2015 (0d) |
| Nov 25, 2015 | KYN | ↑ Buy | 800 | $18.07 | $14K | Direct | Nov 25, 2015 (0d) |
| Nov 17, 2015 | KYN | ↑ Buy | 23,335 | $19.75 | $461K | Direct | Nov 18, 2015 (1d) |
| Nov 13, 2015 | KYN | ↑ Buy | 26,665 | $19.95 | $532K | Direct | Nov 16, 2015 (3d) |
| Jul 31, 2015 | KYN | ↑ Buy | 4,000 | $27.83 | $111K | Direct | Aug 4, 2015 (4d) |
| Apr 30, 2015 | FRPT | ↓ Sell | 2,165,365 | $20.34 | $44.0M | Indirect | Apr 30, 2015 (0d) |
| Nov 30, 2010 | KMF | ↑ Buy | 40,000 | $25.00 | $1.0M | Direct | Nov 30, 2010 (0d) |
| Jan 20, 2009 | KED | ↑ Buy | 10,200 | $10.60 | $108K | Direct | Jan 21, 2009 (1d) |
| Jan 16, 2009 | KED | ↑ Buy | 13,600 | $10.24 | $139K | Direct | Jan 16, 2009 (0d) |
| Jan 7, 2009 | KYN | ↑ Buy | 25,685 | $17.12 | $440K | Direct | Jan 8, 2009 (1d) |
| Dec 31, 2008 | KYE | ↑ Buy | 30,000 | $11.42 | $343K | Direct | Jan 5, 2009 (5d) |
| Dec 31, 2008 | KYN | ↓ Sell | 20,000 | $15.95 | $319K | Direct | Jan 5, 2009 (5d) |
| Nov 28, 2008 | KYE | ↑ Buy | 87,337 | $10.05 | $878K | Direct | Dec 2, 2008 (4d) |
| Nov 28, 2008 | KYN | ↓ Sell | 64,505 | $13.27 | $856K | Direct | Dec 2, 2008 (4d) |
| Nov 26, 2008 | KYE | ↑ Buy | 114,000 | $9.77 | $1.1M | Direct | Nov 26, 2008 (0d) |
| Nov 26, 2008 | KED | ↓ Sell | 120,100 | $9.26 | $1.1M | Direct | Nov 26, 2008 (0d) |
| Apr 11, 2007 | KYN | ↓ Sell | 71,000 | $35.02 | $2.5M | Direct | Apr 17, 2007 (6d) |
| Sep 29, 2006 | KED | ↑ Buy | 23,200 | $22.41 | $520K | Direct | Sep 29, 2006 (0d) |
| Sep 28, 2006 | KED | ↑ Buy | 25,000 | $23.10 | $578K | Direct | Sep 29, 2006 (1d) |
| Sep 25, 2006 | KED | ↑ Buy | 72,000 | $25.00 | $1.8M | Direct | Sep 27, 2006 (2d) |
| Sep 6, 2006 | KYN | ↓ Sell | 300 | $27.85 | $8K | Direct | Sep 12, 2006 (6d) |
| Nov 29, 2005 | HOO | ↑ Buy | 6,900 | $18.01 | $124K | Direct | Dec 1, 2005 (2d) |
| Nov 15, 2005 | KYE | ↑ Buy | 8,080 | $23.25 | $188K | Direct | Nov 17, 2005 (2d) |
| Oct 17, 2005 | KYN | ↑ Buy | 98,900 | $27.04 | $2.7M | Direct | Oct 18, 2005 (1d) |
| Sep 9, 2005 | HOO | ↑ Buy | 15,000 | $21.25 | $319K | Direct | Sep 15, 2005 (6d) |
| Sep 8, 2005 | HOO | ↑ Buy | 24,512 | $21.25 | $521K | Direct | Sep 12, 2005 (4d) |
| Jun 27, 2005 | KYE | ↑ Buy | 80,000 | $25.00 | $2.0M | Direct | Jun 29, 2005 (2d) |
| Jun 8, 2005 | HOO | ↑ Buy | 900 | $20.72 | $19K | Direct | Jun 9, 2005 (1d) |
| Jun 6, 2005 | HOO | ↑ Buy | 4,100 | $20.69 | $85K | Direct | Jun 7, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Richard A Kayne's insider trades
Richard A Kayne is an insider at Eiger BioPharmaceuticals (EIGR). Since Jun 6, 2005, Richard has reported 31 open-market purchases worth $160.8M and 11 sales worth $772.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (21 filings), gifts (12 filings), conversions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIGR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.